Spravato


Have you struggled to treat your depression?

If you have tried medication for your depression and you are not getting better, Spravato® may be right for you.


SPRAVATO® is only available at certified SPRAVATO®
treatment centers under the supervision of a healthcare provider.



SPRAVATO Treatment Center

Depression is a serious illness that is often overlooked and misunderstood. It affects each patient differently and can become so severe that one develops suicidal thoughts or behavior. If you suffer from depression symptoms and have not found relief in medications and therapy such as TMS therapy, SPRAVATO (esketamine treatment) may be a great treatment option for you.

Shrewsbury Medical Group

Shrewsbury Medical Group is a certified SPRAVATO treatment center for patients who suffer from treatment-resistant depression (TRD), or depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. In addition, Talk to our psychiatric provider to find out if you would benefit from Spravato®️ and get back to living life.


Benefits of Care



REMS-Certified Facility


Our healthcare facility is certified in the SPRAVATO Risk Evaluation and Mitigation Strategy (REMS). This is a set of standards developed by the FDA to ensure your safety and well-being as you undergo SPRAVATO treatment in our facility.



Patient-Focused Treatment


We believe that each patient’s journey with depression is unique and must be handled with care. That is why we will create a tailored treatment plan that works best for you, so you can lead a healthy and fulfilling life.



Highly Trained Staff


Our staff is highly trained to dispense and administer SPRAVATO to patients who need it to treat their depression. We have also implemented policies and procedures to ensure the safe handling, storage, and disposal of SPRAVATO in accordance with federal, state, and local regulations and laws.



Healing Environment


Patients who feel comfortable and at ease throughout the recovery process are more likely to remain committed to treatment. Hence, we are devoted to providing compassionate patient care and maintaining a positive atmosphere in our facility.


There is help for TRD and MDD


Talk to our psychiatric provider to find out if you would benefit from Spravato® and get back to living life.

Spravato® plus medication has shown a rapid reduction of depressive symptoms as quickly as 24 hours.

What is SPRAVATO?

SPRAVATO is a nasal spray that contains esketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. Used in conjunction with a traditional oral antidepressant, it is the first and only one of its kind approved to treat 2 subtypes of major depressive disorder (MDD) in adult patients:

Treatment-resistant depression (TRD), which is defined as having failed to respond to 2 or more antidepressant medications at adequate doses during the current episode.

• Depressive symptoms with Major Depressive Disorder (MDD) with acute suicidal thoughts or behavior (MDSI)

SPRAVATO has been proven to reduce depression symptoms within 24 hours, unlike antidepressant medications that take weeks to work. Since depression needs to be treated in a timely manner, this is a great option for patients who need significant symptom relief until a comprehensive, long-term treatment plan becomes available.


How Does SPRAVATO Treatment Work?

SPRAVATO is a nasal spray that contains esketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist. Used in conjunction with a traditional oral antidepressant, it is the first and only one of its kind approved to treat 2 subtypes of Major Depressive
Disorder (MDD) in adult patients:

Treatment-resistant depression (TRD), which is defined as having failed to respond to 2 or more antidepressant medications at adequate doses during the current episode.

• Depressive symptoms with Major Depressive Disorder (MDD) with acute suicidal thoughts or behavior (MDSI)

SPRAVATO has been proven to reduce depression symptoms within 24 hours, unlike antidepressant medications that take weeks to work. Since depression needs to be treated in a timely manner, this is a great option for patients who need significant symptom relief until a comprehensive, long-term treatment plan becomes available.


Who Cannot Undergo SPRAVATO Treatment?

A patient who has any of the following conditions should not undergo SPRAVATO treatment:

• blood vessel disease
• abnormal connection between your veins and arteries
• history of bleeding in the brain
• allergy to any of the ingredients in SPRAVATO

If you and your healthcare provider decide that SPRAVATO could be part of your treatment plan, contact us today.

Spravato Contact Form









    Our mission is to provide quality medical care to the community and bring health and longevity to people.

    © Copyrights 2022. All Rights Reserved.